Company Filing History:
1 out of 2 
1 out of 29 Years Active: 2019
Title: KeeIung Hong: Innovator in Pharmaceutical Compositions
Introduction
KeeIung Hong is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on hydrophobic camptothecin derivatives. His research focuses on developing effective treatments for cancer, showcasing his commitment to advancing medical science.
Latest Patents
KeeIung Hong holds a patent for "Pharmaceutical compositions of hydrophobic camptothecin derivatives." This invention provides a pharmaceutical composition that includes at least one hydrophobic camptothecin derivative or a pharmaceutically acceptable salt of said derivative, combined with a polyethylene glycol (PEG) conjugated phospholipid. The patent also outlines a method to inhibit cancer cells in a subject in need by administering this pharmaceutical composition.
Career Highlights
Throughout his career, KeeIung Hong has worked with several prominent companies in the biopharmaceutical sector. He has been associated with Taiwan Liposome Company, Ltd. and Tlc Biopharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
KeeIung Hong has collaborated with notable colleagues, including Pei Kan and ChiaHung Hung. These partnerships have likely enhanced his research and development efforts, leading to impactful advancements in the pharmaceutical field.
Conclusion
KeeIung Hong's contributions to pharmaceutical compositions and cancer treatment exemplify his dedication to innovation in medicine. His work continues to inspire advancements in the fight against cancer, making a significant impact on the healthcare industry.